Literature DB >> 10750556

Genomic organization of the human chondromodulin-1 gene containing a promoter region that confers the expression of reporter gene in chondrogenic ATDC5 cells.

I Yanagihara1, M Yamagata, N Sakai, C Shukunami, H Kurahashi, M Yamazaki, T Michigami, Y Hiraki, K Ozono.   

Abstract

Chondromodulin-1 (ChM-1) is a cartilage-specific glycoprotein that stimulates the growth of chondrocytes and inhibits the tube formation of endothelial cells. To clarify the tissue-specific expression and the role of ChM-1 in pathophysiological conditions, we analyzed the structure of the human ChM-1 gene and its promoter. On the screening of a human genomic cosmid library using the human ChM-1 complimentary DNA (cDNA) as a probe, two clones were obtained that contained ChM-1 cDNA. The restriction enzyme map and nucleotide sequence revealed the human ChM-1 gene consisting of seven exons and exon-intron boundaries. The human ChM-1 gene was assigned to chromosome 13q14-21 by fluorescence in situ hybridization (FISH) using the clone as a probe. A primer extension analysis using total RNA extracted from human cartilage revealed a major transcription start site with the sequence CGCT+1GG. The region approximately 3-kilobase (kb) nucleotides upstream of the translation start site was then sequenced and analyzed in terms of promoter activity. We found that a region 446 base pairs (bp) upstream of the start site had promoter activity in COS7, HeLa, and ATDC5 cells. In structure the promoter is a TATA-less type without a GC-rich region. The transcription factors Sox9, Og12, and Cart-1 did not affect the promoter activity. The transcription factor Ying-Yang1 suppressed the promoter activity but GABP protein did not change the promoter activity. The construct containing -446/+87 fused to the SV40 enhancer and green fluorescent protein (GFP) exhibited expression of GFP corresponding to the differentiation of ATDC5 cells to mature chondrocytes. These results suggest that the element -446/+87 confers the cartilage-specific expression of this gene by some factor(s) other than Sox9, Og12, and Cart-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750556     DOI: 10.1359/jbmr.2000.15.3.421

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  A functional role of the glycosylated N-terminal domain of chondromodulin-I.

Authors:  Jun Kondo; Hiroyuki Shibata; Shigenori Miura; Akira Yamakawa; Koji Sato; Yoshiki Higuchi; Chisa Shukunami; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-27       Impact factor: 2.626

2.  4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.

Authors:  Dimitrios Stagos; Hongfei Zhou; David Ross; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

3.  Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells.

Authors:  Hongfei Zhou; Jadwiga K Kepa; David Siegel; Shigenori Miura; Yuji Hiraki; David Ross
Journal:  Mol Pharmacol       Date:  2009-06-12       Impact factor: 4.436

Review 4.  Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease.

Authors:  Sipin Zhu; Heng Qiu; Samuel Bennett; Vincent Kuek; Vicki Rosen; Huazi Xu; Jiake Xu
Journal:  Cell Mol Life Sci       Date:  2019-07-17       Impact factor: 9.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.